Related Experiment Video
Updated: May 11, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Fighting Cancer with Photodynamic Therapy and Nanotechnologies: Current Challenges and Future Directions
Laura Marinela Ailioaie1, Constantin Ailioaie1, Gerhard Litscher2,3
1Department of Medical Physics, Alexandru Ioan Cuza University, 11 Carol I Boulevard, 700506 Iasi, Romania.
Abstract:
Photodynamic therapy (PDT) is an innovative treatment that has recently been approved for clinical use and holds promise for cancer patients. It offers several benefits, such as low systemic toxicity, minimal invasiveness, and the ability to stimulate antitumor immune responses. For certain types of cancer, it has shown positive results with few side effects. However, PDT still faces some challenges, including limited light penetration into deeper tumor tissues, uneven distribution of the photosensitizer (PS) that can also affect healthy cells, and the difficulties posed by the hypoxic tumor microenvironment (TME). In hypoxic conditions, PDT's effectiveness is reduced due to insufficient production of reactive oxygen species, which limits tumor destruction and can lead to relapse. This review highlights recent advances in photosensitizers and nanotechnologies that are being developed to improve PDT. It focuses on multifunctional nanoplatforms and nanoshuttles that have shown promise in preclinical studies, especially for treating solid tumors. One of the key areas of focus is the development of PSs that specifically target mitochondria to treat deep-seated malignant tumors. New mitochondria-targeting nano-PSs are designed with better water solubility and extended wavelength ranges, allowing them to target tumors more effectively, even in challenging, hypoxic environments. These advancements in PDT are opening new doors for cancer treatment, especially when combined with other therapeutic strategies. Moving forward, research should focus on optimizing PDT, creating more efficient drug delivery systems, and developing smarter PDT platforms. Ultimately, these efforts aim to make PDT a first-choice treatment option for cancer patients.
Insights
Photodynamic therapy (PDT) is a promising cancer treatment with low toxicity. Recent advances in photosensitizers and nanomedicine are improving PDT effectiveness, especially in challenging tumor environments.
Area of Science:
- Oncology
- Biomedical Engineering
- Nanotechnology
Background:
- Photodynamic therapy (PDT) is an innovative cancer treatment with low toxicity and minimal invasiveness.
- PDT offers potential for stimulating antitumor immune responses and has shown positive results for specific cancers.
- Challenges include limited light penetration, uneven photosensitizer distribution, and the hypoxic tumor microenvironment (TME), which reduces PDT efficacy.
Purpose of the Study:
- To review recent advances in photosensitizers and nanotechnologies for improving photodynamic therapy (PDT).
- To highlight the development of multifunctional nanoplatforms and nanoshuttles for enhanced cancer treatment, particularly for solid tumors.
- To focus on mitochondria-targeting nano-photosensitizers (nano-PSs) for treating deep-seated tumors in hypoxic conditions.
Main Methods:
- Review of recent literature on photosensitizers and nanotechnologies applied to PDT.
- Focus on multifunctional nanoplatforms and nanoshuttles designed for improved drug delivery and targeting.
- Analysis of novel mitochondria-targeting nano-PSs with enhanced water solubility and extended wavelength ranges.
Main Results:
- Development of advanced photosensitizers and nanotechnologies shows promise in preclinical studies.
- Multifunctional nanoplatforms and nanoshuttles improve PDT efficacy, especially for solid tumors.
- Mitochondria-targeting nano-PSs demonstrate improved tumor targeting and effectiveness in hypoxic environments.
Conclusions:
- Recent advancements in photosensitizers and nanotechnologies are significantly improving PDT.
- Targeted delivery systems and mitochondria-specific agents enhance PDT effectiveness, even in challenging tumor conditions.
- Further research into optimizing PDT, drug delivery, and smart platforms aims to establish PDT as a primary cancer treatment.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...